Article Figures & Data
Figures
- Figure 1.
Survival comparison between patients assigned to receive albumin and those assigned to receive saline. Reprinted from reference 10, with permission.
- Figure 2.
Mortality rate by final fluid accumulation relative to baseline weight and stratified by dialysis status. Reprinted from reference 20, with permission.
- Figure 3.
Time course of the daily mean fluid balance while in ICU. ANOVA for repeated measures: *P < 0.05 pairwise compared with each of the two other subgroups; †P < 0.05 compared with the previous time point. Reprinted from reference 22, with permission.
- Figure 4.
Frequency of furosemide and fluid bolus therapies in liberal versus conservative groups. Reprinted from reference 16, with permission.
- Figure 5.
Comparison of cumulative fluid balance at day 7 with baseline between liberal and conservative groups who were (left) shock-free and (right) shock-present. Reprinted from reference 16, with permission.
- Figure 6.
Comparison of cumulative fluid balance in liberal versus conservative groups and previous ARDS network studies (ARMA and ALVEOLI). Reprinted from reference 16, with permission.
- Figure 7.
Stable CVP in liberal fluid group as CVP declines in conservative fluid group. Reprinted from reference 16 and 25, with permission.
- Figure 8.
Events in sepsis and endotoxemia leading to pulmonary edema, hypoxia, mechanical ventilation, ARDS, and high mortality. Reprinted from reference 28, with permission.
Tables
Standard Early Goal P Value MAP (mmHg) 81 ± 16 88 ± 16 <0.001 SCVO2 ≥ 70% 60.2% 94.9% <0.001 CVP, MAP, and UO Goals 86.1% 99.2% <0.001 MAP, mean arterial pressure; UO, urinary output.
↵a Data from reference 2.
Standard Early Goal P Value In-hospital mortality (%) 46.5 30.5 <0.009 SCVO2 (%) 65.3 70.4 <0.02 Lactate (mmol/L) 3.9 3.0 <0.02 PH 7.36 7.4 <0.02 Mechanical ventilation (%) 16.8 2.6 <0.001 Fibrin split product (μg/dl) 62 39 <0.001 ↵a Data from reference 2.
- Table 3.
Effects of albumin infusion on morbidity and mortality due to spontaneous bacterial peritonitisa
Outcome Variable Cefotaxime (n = 63) Cefotaxime + Albumin (n = 63) P Value Renal failure, n (%) 21 (33%) 6 (11%) <0.002 Death in hospital, n (%) 18 (29%) 6 (10%) <0.01 Death at 3 months, n (%) 26 (41%) 14 (22%) <0.03 ↵a Data from reference 12.
In this issue
Jump to section
More in this TOC Section
Cited By...
- AKI Associated with Acute Pancreatitis
- Perspective on Clinical Application of Biomarkers in AKI
- Acute kidney injury
- Is It Time to Evolve Past the Prerenal Azotemia versus Acute Tubular Necrosis Classification?
- Diagnostic Value of Urinary Sodium, Chloride, Urea, and Flow
- Characteristics of Acute Kidney Injury in Patients Infected with the 2009 Influenza A (H1N1) Virus